Jade Biosciences(JBIO)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

JBIO Jade Biosciences

盘前交易 03-10 05:38:34 EDT

14.43

+0.38

+2.70%

最高14.64	最低13.95	成交量50.10万
今开14.44	昨收14.05	日振幅4.91%
总市值7.10亿	流通市值4.76亿	总股本4,922万
成交额720.42万	换手率1.52%	流通股本3,300万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"JBIO","market":"US","secType":"STK","nameCN":"Jade Biosciences","latestPrice":14.43,"timestamp":1773086400000,"preClose":14.05,"halted":0,"volume":500973,"delay":0,"changeRate":0.027046263345195658,"floatShares":33002000,"shares":49218491,"eps":-3.193116,"marketStatus":"盘前交易","change":0.38,"latestTime":"03-10 05:38:34 EDT","open":14.44,"high":14.6403,"low":13.95,"amount":7204185.616551001,"amplitude":0.049132,"askPrice":17.34,"askSize":100,"bidPrice":10.06,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-3.193116,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1773149400000},"marketStatusCode":1,"adr":0,"listingDate":1625025600000,"exchange":"NASDAQ","adjPreClose":14.43,"postHourTrading":{"tag":"盘后","latestPrice":14.43,"preClose":14.43,"latestTime":"16:46 EDT","volume":8615,"amount":124319.68,"timestamp":1773089169034,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.9488926904855912,"impliedVol":0.6535,"impliedVolPercentile":0.4478},"requestUrl":"/m/hq/s/JBIO","defaultTab":"news","newsList":[{"id":"1135114107","title":"Jade Biosciences预计2026年中启动IgAN患者二期临床试验 初步数据有望2027年公布","url":"https://stock-news.laohu8.com/highlight/detail?id=1135114107","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1135114107?lang=zh_cn&edition=full","pubTime":"2026-03-06 20:05","pubTimestamp":1772798719,"startTime":"0","endTime":"0","summary":"Jade Biosciences宣布，公司计划于2026年中期启动针对IgA肾病（IgAN）患者的二期临床试验。根据最新规划，该项研究的初步数据预计将在2027年正式披露。\n此次临床试验的推进标志着公司在肾脏疾病治疗领域取得重要进展。通过二期试验，研究人员将深入评估候选药物的安全性与有效性，为后续临床开发提供关键依据。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","JBIO","BK4139"],"gpt_icon":0},{"id":"1106105650","title":"Jade Biosciences公司：截至2025年12月31日持有3.36亿美元现金及投资，预计资金可支撑运营至2028年上半年","url":"https://stock-news.laohu8.com/highlight/detail?id=1106105650","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1106105650?lang=zh_cn&edition=full","pubTime":"2026-03-06 20:03","pubTimestamp":1772798594,"startTime":"0","endTime":"0","summary":"截至2025年12月31日，Jade Biosciences公司持有的现金、现金等价物及投资总额达到3.36亿美元。这一资金规模预计将为公司提供充足的运营支持，使其能够持续开展研发与商业活动直至2028年上半年。\n充足的流动性为Jade Biosciences推进其生物科技管线提供了战略灵活性。公司管理层表示，现有资金将重点用于核心项目的临床研究和技术平台优化。财务储备的稳定性有助于降低短期融资需求带来的不确定性，为长期价值创造奠定基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4539","JBIO"],"gpt_icon":0},{"id":"2605960287","title":"Jade Biosciences, Inc.盘中异动 早盘急速下跌5.64%报16.06美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2605960287","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605960287?lang=zh_cn&edition=full","pubTime":"2026-01-23 22:34","pubTimestamp":1769178875,"startTime":"0","endTime":"0","summary":"北京时间2026年01月23日22时34分，Jade Biosciences, Inc.股票出现异动，股价急速跳水5.64%。Jade Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.17%。Jade Biosciences, Inc.公司简介：Jade Biosciences Inc专注于开发疗法，以解决自身免疫性疾病中尚未满足的关键需求。Jade是基于 Fairmount创立的抗体发现引擎Paragon Therapeutics许可的资产推出的。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026012322343697a32868&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026012322343697a32868&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","JBIO","BK4139"],"gpt_icon":0},{"id":"1166711556","title":"Jade Biosciences申请出售320万股普通股- SEC备案","url":"https://stock-news.laohu8.com/highlight/detail?id=1166711556","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1166711556?lang=zh_cn&edition=full","pubTime":"2025-12-23 05:41","pubTimestamp":1766439668,"startTime":"0","endTime":"0","summary":"Jade Biosciences申请出售320万股普通股- SEC备案","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4139","JBIO"],"gpt_icon":0},{"id":"1168065668","title":"Jade Biosciences提交最多1610万股普通股的出售申请 - SEC备案","url":"https://stock-news.laohu8.com/highlight/detail?id=1168065668","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1168065668?lang=zh_cn&edition=full","pubTime":"2025-11-20 01:50","pubTimestamp":1763574644,"startTime":"0","endTime":"0","summary":"11月14日 - Jade Biosciences Inc: *Jade Biosciences Inc提交最多1610万股普通股的出售申请 - SEC备案","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JBIO","BK4139","BK4539"],"gpt_icon":0},{"id":"1138728748","title":"Jade Biosciences Inc 提交出售股东最多 1610 万股普通股的注册申请 - SEC备案","url":"https://stock-news.laohu8.com/highlight/detail?id=1138728748","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1138728748?lang=zh_cn&edition=full","pubTime":"2025-11-15 05:16","pubTimestamp":1763154970,"startTime":"0","endTime":"0","summary":"Jade Biosciences Inc 提交出售股东最多 1610 万股普通股的注册申请 - SEC备案","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","JBIO","BK4539"],"gpt_icon":0},{"id":"1176630375","title":"Jade Biosciences宣布推出Jade201——一款在研的潜在同类最佳半衰期延长去岩藻糖化抗BAFF受体单克隆抗体，用于治疗自身免疫性疾病","url":"https://stock-news.laohu8.com/highlight/detail?id=1176630375","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1176630375?lang=zh_cn&edition=full","pubTime":"2025-10-07 19:05","pubTimestamp":1759835128,"startTime":"0","endTime":"0","summary":"Jade Biosciences宣布推出Jade201——一款在研的潜在同类最佳半衰期延长去岩藻糖化抗BAFF受体单克隆抗体，用于治疗自身免疫性疾病。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","JBIO","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.jadebiosciences.com","stockEarnings":[{"period":"1week","weight":0.022},{"period":"1month","weight":-0.0581},{"period":"3month","weight":0.0689},{"period":"6month","weight":0.905},{"period":"1year","weight":-0.837},{"period":"ytd","weight":-0.0648}],"compareEarnings":[{"period":"1week","weight":-0.0118},{"period":"1month","weight":-0.0179},{"period":"3month","weight":-0.007},{"period":"6month","weight":0.04},{"period":"1year","weight":0.1777},{"period":"ytd","weight":-0.0054}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Jade Biosciences, Inc.是内华达州的一家公司，专注于开发一流的疗法，以解决自身免疫性疾病中关键的未满足需求。其牵头资产JADE-001针对免疫球蛋白A（IGA）肾病的细胞因子抗-A PRoliferation诱导Ligand（APRIL），正在进行研究性新药应用赋能研究，预计将于2025年下半年启动首次人体试验。Jade的管线还包括两个未公开的抗体发现项目，JADE-002和JADE-003，目前处于临床前开发阶段。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":-0.072791},{"month":2,"riseRate":0.4,"avgChangeRate":-0.004913},{"month":3,"riseRate":0.6,"avgChangeRate":0.19646},{"month":4,"riseRate":0.25,"avgChangeRate":-0.36998},{"month":5,"riseRate":0,"avgChangeRate":-0.15923},{"month":6,"riseRate":0.75,"avgChangeRate":-0.046284},{"month":7,"riseRate":0.6,"avgChangeRate":-0.036},{"month":8,"riseRate":0.6,"avgChangeRate":0.058197},{"month":9,"riseRate":0.6,"avgChangeRate":0.018606},{"month":10,"riseRate":0.6,"avgChangeRate":0.005142},{"month":11,"riseRate":0.6,"avgChangeRate":0.137722},{"month":12,"riseRate":0.8,"avgChangeRate":0.213367}],"exchange":"NASDAQ","name":"Jade Biosciences","nameEN":"Jade Biosciences"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Jade Biosciences(JBIO)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Jade Biosciences(JBIO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Jade Biosciences,JBIO,Jade Biosciences股票,Jade Biosciences股票老虎,Jade Biosciences股票老虎国际,Jade Biosciences行情,Jade Biosciences股票行情,Jade Biosciences股价,Jade Biosciences股市,Jade Biosciences股票价格,Jade Biosciences股票交易,Jade Biosciences股票购买,Jade Biosciences股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Jade Biosciences(JBIO)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Jade Biosciences(JBIO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}